Waldencast PLC (NASDAQ:WALD) is set to release its Q4 2024 earnings on Mar 18, 2025. The consensus estimate for Q4 2024 ...

Full Year 2024 Results Key Financial Results Revenue: US$273.9m (up 26% from FY 2023).

Telsey Advisory Group reiterated their outperform rating on shares of Waldencast (NASDAQ:WALD – Free Report) in a research note published on Wednesday morning,Benzinga reports. Telsey Advisory Group ...

TD Cowen lowered the firm’s price target on Waldencast (WALD) to $3.40 from $4.30 and keeps a Hold rating on the shares. The firm updated its ...

CEO Michel Brousset highlighted that 2024 was a transformative year for Waldencast, driven by strong performance from its two flagship brands: Milk Makeup and Obagi Medical. He emphasized their ...

Waldencast Acquisition Corp (WALD) reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of -$0.06, slightly missing analysts’ expectations of -$0.0524. The company ...

Telsey Advisory lowered the firm’s price target on Waldencast (WALD) to $5 from $6 and keeps an Outperform rating on the shares. The firm ended ...

Waldencast PLC (WALD) reports robust revenue increases and secures a new credit facility, positioning for future growth despite macroeconomic challenges.

Waldencast Acquisition Corp (WALD) reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of -$0.06, slightly missing analysts’ expectations of -$0.0524. The company’s ...

Waldencast’s 2024 sales estimate is $81.69M, with an expected loss of 1 cent per share. Obagi Medical sales grew 37.4% in Q3, while Milk Makeup sales rose 23.5%. Pelosi’s latest AI pick ...